Simeprevir is a potent, selective hepatitis C virus NS3/4A serine protease inhibitor used in combination with other therapeutic agents to treat chronic hepatitis C infection. The range of associated reference… Read more
Simeprevir is a potent, selective hepatitis C virus NS3/4A serine protease inhibitor used in combination with other therapeutic agents to treat chronic hepatitis C infection. The range of associated reference materials, including pharmacopeial and non-pharmacopeial impurities, serves as a critical resource for analytical laboratories engaged in stringent quality control and drug development. Stable isotope labelled compounds, such as deuterium and carbon-13 variants, function as essential internal standards for mass spectrometry-based assays, enabling precise quantification of the drug in biological matrices. By utilizing these high-quality reference standards, analytical chemists can facilitate rigorous impurity profiling, perform accurate method validation, and support pharmacokinetic studies. This collection supports the development and maintenance of robust testing protocols required for the verification of simeprevir purity and stability throughout its lifecycle.